TMPRSS4: A Novel Tumor Prognostic Indicator for the Stratification of Stage IA Tumors and a Liquid Biopsy Biomarker for NSCLC Patients
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TMPRSS4: A Novel Tumor Prognostic Indicator for the Stratification of Stage IA Tumors and a Liquid Biopsy Biomarker for NSCLC Patients
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 8, Issue 12, Pages 2134
Publisher
MDPI AG
Online
2019-12-04
DOI
10.3390/jcm8122134
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma
- (2019) Yang Cheng et al. EBioMedicine
- Targeting of TMPRSS4 sensitizes lung cancer cells to chemotherapy by impairing the proliferation machinery
- (2019) Francisco Exposito et al. CANCER LETTERS
- Anti-cancer activity of the novel 2-hydroxydiarylamide derivatives IMD-0354 and KRT1853 through suppression of cancer cell invasion, proliferation, and survival mediated by TMPRSS4
- (2019) Solbi Kim et al. Scientific Reports
- A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients
- (2018) Elena Martínez-Terroba et al. JOURNAL OF PATHOLOGY
- An epigenetic classifier for early stage lung cancer
- (2018) Yun Su et al. Clinical Epigenetics
- Efficacy of adjuvant chemotherapy for completely resected stage IB non-small cell lung cancer: a retrospective study
- (2018) Hye Jung Park et al. Journal of Thoracic Disease
- Should patients with stage IB non-small cell lung cancer receive adjuvant chemotherapy? A comparison of survival between the 8th and 7th editions of the AJCC TNM staging system for stage IB patients
- (2018) Jia Wang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges
- (2018) Luis M. Seijo et al. Journal of Thoracic Oncology
- Validation of the SHOX2 / PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease
- (2017) Gunter Weiss et al. Journal of Thoracic Oncology
- Translating cancer epigenomics into the clinic: focus on lung cancer
- (2017) Josep Mari-Alexandre et al. Translational Research
- TMPRSS4 induces cancer stem cell-like properties in lung cancer cells and correlates with ALDH expression in NSCLC patients
- (2016) Arrate L. de Aberasturi et al. CANCER LETTERS
- A Novel Epigenetic Signature for Early Diagnosis in Lung Cancer
- (2016) A. Diaz-Lagares et al. CLINICAL CANCER RESEARCH
- The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
- (2016) Peter Goldstraw et al. Journal of Thoracic Oncology
- Total and mutated EGFR quantification in cell-free DNA from non-small cell lung cancer patients detects tumor heterogeneity and presents prognostic value
- (2016) E. Alegre et al. TUMOR BIOLOGY
- Epigenetic alterations leading to TMPRSS4 promoter hypomethylation and protein overexpression predict poor prognosis in squamous lung cancer patients
- (2016) Maria Villalba et al. Oncotarget
- TMPRSS4 facilitates epithelial-mesenchymal transition of hepatocellular carcinoma and is a predictive marker for poor prognosis of patients after curative resection
- (2015) Cheng-Hao Wang et al. Scientific Reports
- Quantification of Cell-Free mSHOX2 Plasma DNA for Therapy Monitoring in Advanced Stage Non-Small Cell (NSCLC) and Small-Cell Lung Cancer (SCLC) Patients
- (2015) Bernd Schmidt et al. PLoS One
- Biomarkers in Early-Stage Non–Small-Cell Lung Cancer: Current Concepts and Future Directions
- (2014) Mauricio Burotto et al. Journal of Thoracic Oncology
- TMPRSS4 as a Poor Prognostic Factor for Triple-Negative Breast Cancer
- (2013) Daye Cheng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Prognostic value of TMPRSS4 expression in patients with breast cancer
- (2013) Bin Liang et al. MEDICAL ONCOLOGY
- Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
- (2012) Douglas G. Altman et al. PLOS MEDICINE
- SHOX2 DNA Methylation Is a Biomarker for the Diagnosis of Lung Cancer in Plasma
- (2011) Christoph Kneip et al. Journal of Thoracic Oncology
- SHOX2 DNA Methylation is a Biomarker for the diagnosis of lung cancer based on bronchial aspirates
- (2010) Bernd Schmidt et al. BMC CANCER
- The DNA methylome of glioblastoma multiforme
- (2010) Ramon Martinez et al. NEUROBIOLOGY OF DISEASE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started